Shareholder of CCJ (CCJ) plans Rule 144 sale of 1,000 common shares
Rhea-AI Filing Summary
A shareholder filed a Rule 144 notice to sell 1,000 common shares of the issuer through broker Solium Financial Inc. on or about 01/05/2026 on the NYSE. The filing lists an aggregate market value of 100170.00 for these shares and notes that 435457978 shares were outstanding. The shares to be sold were acquired on 03/03/2023 as a vesting of a long-term incentive (LTI) award, with payment made in cash on the same date.
By signing the notice, the selling shareholder represents that they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, and is reminded that intentional misstatements or omissions can constitute federal criminal violations.
Positive
- None.
Negative
- None.
FAQ
How many CCJ shares are planned to be sold under this Rule 144 notice?
The notice states that the shareholder plans to sell 1,000 common shares of the issuer.
What is the aggregate market value of the CCJ shares to be sold?
The aggregate market value of the 1,000 common shares to be sold is listed as 100170.00.
When were the CCJ shares to be sold under Rule 144 originally acquired?
The shares were acquired on 03/03/2023 as shares vested from a long-term incentive (LTI) award, with payment made in cash on the same date.
What is the approximate planned sale date for these CCJ shares?
The approximate date of sale listed for the 1,000 common shares is 01/05/2026.
How many issuer shares were outstanding when this CCJ Rule 144 notice was prepared?
The filing states that there were 435457978 shares outstanding for the issuer at the time referenced.
Which broker is handling the planned sale of CCJ shares under this Rule 144 filing?
The planned sale of 1,000 common shares is to be handled by Solium Financial Inc., located in Calgary.
What representation does the selling shareholder make in this CCJ Rule 144 notice?
The shareholder represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed and is warned that intentional misstatements or omissions can constitute federal criminal violations.